Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis
Ni Kong, Qin Xu, Wei Cui, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 22, pp. 1205-1205
Open Access | Times Cited: 18

Showing 18 citing articles:

Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Anna De Bartolo, Tommaso Angelone, Carmine Rocca
Vascular Pharmacology (2025), pp. 107462-107462
Closed Access | Times Cited: 1
Lipid metabolism disorder promotes the development of intervertebral disc degeneration
Jun Yi, Qingluo Zhou, Jishang Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115401-115401
Open Access | Times Cited: 23
The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 917-937
Open Access | Times Cited: 8
Pathophysiology of Acute Coronary Syndromes—Diagnostic and Treatment Considerations
Panagiotis Theofilis, Evangelos Oikonomou, Christos Chasikidis, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1543-1543
Open Access | Times Cited: 16
Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment
Panagiotis Theofilis, Panayotis K. Vlachakis, Aggelos Papanikolaou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5786-5786
Open Access | Times Cited: 5
Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
Yanan Wang, Dan Fang, Qinzhi Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Research Progress of PCSK9 in Clinical Practice
艳丽 胡
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 200-207
Closed Access
Immunotherapy and vaccine-based approaches for atherosclerosis prevention: a systematic review study
Mansoureh Shekarchizadeh Esfahani, Mansour Siavash, Raheleh Sadat Sajad, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
Minglu Ma, Chang Hou, Jian Liu
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
PCSK9 inhibitor attenuates atherosclerosis by regulating SNHG16/EZH2/TRAF5‐mediated VSMC proliferation, migration, and foam cell formation
Yan Liu, Yueyan Zhao, Panyang Feng, et al.
Cell Biology International (2023) Vol. 47, Iss. 7, pp. 1267-1280
Closed Access | Times Cited: 8
Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
Panagiotis Theofilis, Evangelos Oikonomou, Christos Chasikidis, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1211-1211
Open Access | Times Cited: 7
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review)
Shan Chong, Guangyan Mu, Xinan Cen, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 6
Open Access | Times Cited: 2
E3 ubiquitin ligase MARCH1 reduces inflammation and pyroptosis in cerebral ischemia-reperfusion injury via PCSK9 downregulation
Hongmei Guo, Wanli Li, Zhi‐gang Yang, et al.
Mammalian Genome (2024) Vol. 35, Iss. 3, pp. 346-361
Closed Access | Times Cited: 1
Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications
Omonzejie E. Imaralu, Chandrakala Aluganti Narasimhulu, Pawan K. Singal, et al.
Canadian Journal of Physiology and Pharmacology (2023) Vol. 102, Iss. 01, pp. 14-25
Closed Access | Times Cited: 3
Sirtuin 6 Deacetylates Apoptosis-Associated Speck-Like Protein (ASC) to Inhibit Endothelial Cell Pyroptosis in Atherosclerosis
Jian Huang, Shuilin Dong, Yanhui Wu, et al.
International Heart Journal (2024) Vol. 65, Iss. 3, pp. 466-474
Open Access
Non-Coding RNA Involved in the Pathogenesis of Atherosclerosis—A Narrative Review
Kajetan Kiełbowski, Justyna Żychowska, Estera Bakinowska, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1981-1981
Open Access
Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis?
Ulrich Julius, Sergey Tselmin, В. А. Корнева
Russian Journal of Cardiology (2024) Vol. 29, Iss. 8, pp. 6069-6069
Open Access
Page 1

Scroll to top